arrow_back Entities

NRG THERAPEUTICS LTD

active Private Limited Company
🇬🇧 GB | Incorporated 2018-04-05 | Reg. 11294505 | Data as of 2026-06-01
72110 - Research and experimental development on biotechnology

NRG THERAPEUTICS LTD is a private limited company registered in the United Kingdom, under 11294505, incorporated on 5 April 2018. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 8 years. Registered office address: SG1 2FX Stevenage, the United Kingdom. Directors include MR GRANT HAWTHORNE, MR FRANCESCO DRAETTA, and GEORGIA ROSE FROST, and 5 others. Sole shareholder is PARKINSON'S RESEARCH VENTURES LIMITED. Associated with 6 related entities, including SYNAPTIKOS CONSULTING LIMITED, LOQUS23 THERAPEUTICS LIMITED, and VIVIFI BIOTECH LIMITED. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.

bookmark_add Save this entity to a watchlist · Get alerts on changes · API access
Sign up free

Official Identifiers

REGISTRATION NUMBER 11294505

Registered Address

STEVENAGE BIOSCIENCE CATALYST
GUNNELS WOOD ROAD
HERTS
SG1 2FX STEVENAGE
the United Kingdom

Signal Intelligence

verified

No sanctions, PEP status, or adverse risk signals are currently on record for this entity.

Key Management & Controllers

SECRETARY
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
25-50% SHAREHOLDER

Associated Entities

Companies sharing one or more directors or officers with this entity.

Change Log (6)

Date Change Details
2026-04-19 DIRECTOR ADDED Dr Jonathan Rex Savidge (director)
2026-04-19 DIRECTOR ADDED Claudio Nessi (director)
2026-04-19 DIRECTOR ADDED Dr Neil Derek Miller (director)
2026-04-19 DIRECTOR ADDED Dr Florian Muellershausen (director)
2026-04-19 DIRECTOR ADDED Francesco Draetta (director)
2026-04-19 DIRECTOR ADDED Charlotte Johanna Pauline Kremers (director)

Source Records (1)

companieshouse 11294505 2026-06-01 open_in_new
Save entities, get alerts on changes, API access Sign up free